Education
About Us
Working with TipRanks
Follow Us
Reckitt (GB:RKT)
LSE:RKT
RKT Stock Chart & Stats
Day’s Range― - ―
52-Week Range4,034.00p - 5,418.00p
Previous CloseN/A
Volume39.10K
Average Volume (3M)1.60M
Market Cap
£35.49B
Enterprise Value38.31B
Total Cash (Recent Filing)£1.39B
Total Debt (Recent Filing)£8.54B
Price to Earnings (P/E)25.5
Beta0.57
Next Earnings
Jul 24, 2025EPS Estimate
154Next Dividend Ex-Date
Apr 10, 2025Dividend Yield3.78%
Share Statistics
EPS (TTM)2.03
Shares Outstanding683,207,400
10 Day Avg. Volume1,411,343
30 Day Avg. Volume1,595,875
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.48
Price to Cash Flow (P/CF)18.10
P/FCF Ratio18.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
5,662.00pPrice Target Upside10.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
---
Reckitt News
---
Bulls Say, Bears Say
Bulls Say
Management And Shareholder ValueThe management team at Reckitt is considered the most credible CEO/CFO/Chair combination for over a decade, showing a clear commitment to shareholder value.
Operational EfficiencyThe underlying operating margin exceeded expectations due to effective cost-saving measures.
Stock ValuationThe stock is trading at a significant discount compared to its peers, making it an attractive investment opportunity.
Bears Say
Growth ConcernsReckitt expects LFL growth of +2% to +4% for the Group, which is below consensus of +4.4%.
Litigation And Legal ChallengesThe decision for a retrial in the Whitfield case against Reckitt has led to a perception of market risk.
Sales PerformanceSales growth and guidance for the next year are not strong enough to counterbalance the positive margin results.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.02% Insiders
15.65%
Mutual Funds
<0.01% Other Institutional Investors
72.39% Public Companies and
Individual Investors
RKT FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest share price was 4034.00p and its highest was 5418.00p in the past 12 months.
What is Reckitt’s market cap?
Reckitt’s market cap is £35.49B.
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Jul 24, 2025 which is in 121 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Mar 06, 2025. The company reported 1.878p earnings per share for the quarter, beating the consensus estimate of 1.54p by 0.338p.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt pays a Annually dividend of 121.7p which represents an annual dividend yield of 3.78%. See more information on Reckitt dividends here
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is 154.
How many shares outstanding does Reckitt have?
Reckitt has 683,207,400 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of 1.878p in its last earnings report, beating expectations of 1.54p. Following the earnings report the stock price went up 2.083%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in GB:RKT
---
Reckitt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
5,662.00p (10.37% Upside)
5,662.00p (10.37% Upside)
Blogger Sentiment
Bullish
GB:RKT Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth £196.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.56%
12-Months-Change
Fundamentals
Return on Equity
18.88%
Trailing 12-Months
Asset Growth
-6.77%
Trailing 12-Months
Company Description
Reckitt
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
---
RKT Stock 12 Month Forecast
Average Price Target
5,662.00p
▲(10.37% Upside)
Technical Analysis
Best Analysts Covering RKT
1 Year
1 Year Success Rate
21/51 ratings generated profit
1 Year Average Return
-3.64%
reiterated a buy rating 7 days ago
Copying James Edwardes Jones's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of -3.64% per trade.
---